Risk factors for delayed duodenal ulcer healing during treatment with ranitidine (300 mg daily) were examined in a multicentre German study of 1923 patients with endoscopicaily proved, recurrent-duodenal ulceration. Healing rates, per protocol, were 39-5% at two weeks, 70-9% at four weeks, and 93-2% at eight weeks. Prospective testing of five, predefined risk factors indicated that smoking (p=0-0039) was associated with a decreased healing rate at two weeks. Frequent prior recurrence (p=0464), a heavy physical workload (p=0-145), and' psychological stress (p=0062) were not associated with a decreased healing rate and there were too few patients at risk to aliow assessment of the effect of regular NSAID intake. Exploratory analysis identified prior slow healing, a large ulcer, multiple ulcers, and prior ulcer complications, in addition to smoking, as markers of slow healing. In the absence of these risk factors, the mean healing time was 3*3 weeks (95% confidence interval 3-0, 3.5), rising to 3*7 weeks (3.5, 3.9) for one, 4*4 weeks (4.1, 4.7) for two, and 5-1 weeks (4.5, 5.6) for three to five risk factors. Delayed duodenal ulcer healing is associated with multiple factors whose effect is cumulative; for patients with two or more of five easily identified risk factors, more than four weeks' treatment with a histamine H2 receptor antagonist is required to achieve ulcer healing.
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There is, however, a number of obstacles to the identification of risk factors for slow healing. It To minimise the problems outlined above, the risk factors for delayed ulcer healing were studied during the initial healing phase of a prospective, multicentre study (Recurrence of Ulcers of the Duodenal bulb: Epidemiology during Ranitidine treatment -RUDER) which was designed to enrol a minimum of 1280 patients suffering from endoscopically confirmed, recurrent duodenal ulceration. All patients received the same treatment until endoscopically confirmed healing had occurred. Ranitidine (300 mg daily) was chosen since it is currently the most widely used ulcer treatment. On the basis of previous studies, five prospectively defined hypotheses were tested; namely, that smoking, a high prior duodenal ulcer recurrence rate, physical workload, mental stress, and intake of non-steroidal anti-inflammatory drugs (NSAIDs) are associated with delayed healing during ranitidine treatment. Additional potential risk factors for delayed healing were examined in a subsequent exploratory analysis.
Methods

SELECTION OF HYPOTHESES
At the outset, five hypotheses were selected prospectively on the grounds that they were refutable within the context of the study design, that they were of relevance to current duodenal ulcer research, or that they were of potential importance for both ulcer healing and ulcer recurrence. Specifically, the study tested the hypothesis that the duodenal ulcer healing rates after two weeks' treatment were lower in the presence of:
(1) A history ofsmoking, either currently or in the past; (2) A high prior recurrence rate (two or more episodes of duodenal ulceration during the previous two years); (3) A heavy physical workload; (4) At the first, two week follow up appointment, endoscopy to assess ulcer healing was obligatory. At this, and all subsequent follow up appointments, the physician also noted concomitant illnesses and medical treatment and repeated his personal assessments of the patient's stress, symptom severity, fitness for work, and compliance with treatment. If the ulcer had healed, the patient started a maintenance regimen of ranitidine (150 mg at night) otherwise he or she was given an additional supply of ranitidine (300 mg at night). The timing of all subsequent follow up appointments and endoscopies in the healing phase was discretionary. The final information sheet for the healing phase was completed only when ulcer healing had been confirmed endoscopically, at which time the patient was transferred to the maintenance treatment regimen.
Overall, patients were deemed to be psychologically stressed if the physician had noted stress at any of the scheduled appointments. The data relating to the patients' dietary habits were collected after endoscopically confirmed ulcer healing in 985 patients to assess their habitual intake in relation to their normal physical activity, in the absence of active ulceration. Patients kept a detailed record of their food consumption over a three day period before their first follow up appointment in the maintenance phase of the study and also described their normal physical activity. An overall activity index (graded from 2 to 9) was then calculated on the basis of the patient's activity (graded from 1 24 weeks in 29 patients (1-51%), and greater than 24 weeks in seven patients (0 36%). After eight weeks, a further four patients eventually underwent surgery for failure to heal, two were lost to follow up, and four were deemed to have resistant ulcers (Fig 1) .
PROSPECTIVE ANALYSIS
Of the five prospectively defined risk factors, only smoking was associated with a significant increase in the proportion of slow healers after both univariate and stepwise logistic regression analyses (Table III) . Smoking was also associated with a decreased healing rate at four and eight weeks (Fig 2) (Fig 2) . Prior slow healing was associated with decreased two, four, and eight week healing rates while ulcers greater than 15 mm in diameter and multiple ulcers were associated with decreased healing rates at two and four weeks. Slow healing was also seen: (1) at two weeks in association with prior complications, unemployment, a deformed duodenal bulb at healing, and an excessive dietary intake; (2) at four weeks in association with divorce; and (3) at eight weeks in association with abstention from wine. Of the 10 risk factors associated with delayed healing, ulcers larger than 15 mm, smoking, multiple ulcers, and prior slow healing were associated with odds ratios for delayed healing which were significantly greater than 1 00 at two or more time points (Fig 2) In the present study, smoking was associated with a decreased duodenal ulcer healing rate at 0 two, four, and eight weeks; no other predefined Many previous studies have sought risk factors retrospectively in the context of trials designed primarily to detect a difference between antiulcer treatments. In these studies, multiple treatment variables with relatively few patients in each risk factor group have precluded detection of changes in the healing rate associated with non-pharmacological risk factors whose effects are usually smaller than those due to ulcer therapy. The present study was therefore designed to recruit a large number of patients, all of whom received the same treatment, allowing unequivocal refutation of the prospectively defined hypotheses that a heavy physical workload and a high prior recurrence rate are associated with a decreased healing rate. Although stress (assessed dichotomously by the physician) was not associated with slow healing, closer analysis of the data showed that continuous, but not intermittent, stress was associated with slow healing.37 A deleterious effect of regular NSAID intake on ulcer healing cannot be excluded since there were few patients at risk. Indeed, there were fewer patients than expected taking NSAIDs, perhaps since intake had been reduced because of chronic duodenal ulcer disease. That said, the prevalence of NSAID intake was not significantly lower than that reported in an Australian community prevalence study38 after correction for a lower proportion of women in the present study.
The clinical relevance of the risk factors identified by exploratory statistical testing in the present study should be confirmed in future, prospective studies of appropriate size but factors which were found not to be associated with slow healing can be presumed to be clinically unimportant. In the present study, five risk factors were considered to be clinically relevant because they were associated, at a minimum of two assessment points, with a decreased healing rate. The effect of these factors was cumulative in that the proportion of patients unhealed at each time point and the mean time to healing increased progressively with the number of risk factors to which the patient was exposed.
The data from this study confirm that nonpharmacological factors are important determinants ofduodenal ulcer healing during treatment with a histamine H2 receptor antagonist and that healing processes are affected by multiple factors whose effects are cumulative. With the exception of smoking, the most important risk factors identified in this study are markers of a diathesis for slow healing and are not amenable to modification. Furthermore, although smoking habits can be modified, this may not affect ulcer healing since the healing rate in ex-smokers was comparable with that in patients who continued to smoke.32 Thus, the main purpose of identifying these risk factors in clinical practice is to allow the physician to decide which patients will require more prolonged or more potent ulcer treatment. On the basis of the present study, patients with two or more of the following risk factors -prior slow healing, smoking, a large ulcer, prior complications, and multiple ulcersshould receive treatment with a histamine H2 receptor antagonist for more than four weeks.
